NCT03495882: A Study of Zalifrelimab and Balstilimab for Treatment of Participants With Metastatic or Locally Advanced Solid Tumors, and Expansion Into Select Solid Tumors (Cervical)

Sponsor: Agenus Inc.. Phase: PHASE1. Conditions: Cervical Cancer